eVTOL Stock Face-Off: Is Joby Aviation or Archer Aviation the Better Buy Right Now?

Joby Aviation and Archer Aviation remain pre-commercial eVTOL names facing FAA approval risk, with first U.S. commercial flights likely delayed until late 2026 or 2027. Analysts still expect Joby revenue to rise from $53 million in 2025 to $458 million in 2028, and Archer revenue from under $1 million to $482 million, but both are still loss-making and trading on highly speculative long-term forecasts. The article argues Joby is the better long-term buy, despite Archer's lower 2028 sales multiple of 8x versus Joby's 20x.

Analysis

The market is still pricing JOBY and ACHR like binary pre-revenue SPAC remnants, but the real setup is a regulatory optionality trade: once certification credibility improves, multiple expansion will likely matter more than near-term unit economics. The key second-order effect is that the first FAA-path winner will likely absorb disproportionate capital, supplier allocation, and partner attention, while the laggard gets left with a higher cost of capital and weaker bargaining power on manufacturing and route partnerships.

JOBY’s premium is harder to dismiss than it looks because a vertically integrated operating model creates a built-in data and utilization flywheel: every early flight becomes evidence for regulators, insurers, fleet operators, and municipal buyers. That said, the market may be underestimating the dilution risk embedded in the scale-up phase; if commercialization slips into 2027, the current valuation still assumes a fairly clean transition from prototype to network operator, which is a dangerous assumption for an aviation business.

ACHR screens cheaper, but the lower multiple reflects a more fragile path to monetization: OEM economics are more cyclical, more exposed to order deferrals, and more dependent on a healthy third-party fleet ecosystem that does not yet exist. The best contrarian angle is that the “winner” may not be the better aircraft design but the company with the strongest certification execution and balance sheet resilience; in that framework, any FAA milestone that de-risks the timeline could trigger a sharp re-rating in both names, but a delay would likely punish ACHR first and hardest.

For the broader tape, the announcement is mildly supportive for DAL/UAL/STLA/Uber ecosystem narratives, but the real beneficiaries may be suppliers and defense-adjacent contractors if certification pushes more outsourcing and validation work into the chain. BA is a useful read-through: any incremental aerospace certification confidence helps sentiment, but EVtol is still a much smaller, more sentiment-sensitive capital market story than a true industrial demand cycle.

Key Decisions for Investors

• Long JOBY / short ACHR for the next 6-12 months as a relative-value expression on certification credibility and balance-sheet durability; target a 20-30% spread widening if FAA milestones remain on schedule.
• Buy JOBY January 2027 calls or call spreads into weakness, not strength; the payoff is convex if the market starts discounting commercial operations, but avoid paying up before a catalyst window where delay risk is still unresolved.
• Short ACHR against a basket of UAL and DAL if you want to isolate execution risk from ecosystem beta; ACHR is more exposed to timeline slips and OEM order pushouts, while the airlines can still benefit from optionality without same-factor dilution.
• Hold off on adding until any FAA-related confirmation; the next 3-9 months are about regulatory headlines, not revenue. Use pullbacks tied to delay fears as the only entry points.
• For higher risk tolerance, structure a small long volatility position in both names around certification events; the upside re-rating from a single approval-step surprise is likely larger than the market is currently pricing, but time decay is severe if approvals slip into 2027.